Analytical Data
-
Gene name
C11orf49
- Application
-
Alternative Names
C11orf49UPF0705 Protein C11orf49
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H6J7
-
Expression Region
1-331aa
-
AA Sequence
MLSPERLALP DYEYLAQRHV LTYMEDAVCQ LLENREDISQ YGIARFFTEY FNSVCQGTHI LFREFSFVQA TPHNRVSFLR AFWRCFRTVG KNGDLLTMKE YHCLLQLLCP DFPLELTQKA ARIVLMDDAM DCLMSFSDFL FAFQIQFYYS EFLDSVAAIY EDLLSGKNPN TVIVPTSSSG QHRQRPALGG AGTLEGVEAS LFYQCLENLC DRHKYSCPPP ALVKEALSNV QRLTFYGFLM ALSKHRGINQ ALGALPDKGD LMHDPAMDEE LERLLAQVPG LVNSVTASPE ASCLPSRTPP RVGSPWRPLH HSRKVDGESD GSTEETDESE T
-
Molecular Weight
37.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C11orf49, also known as the "C11 open reading frame 49," has garnered attention in recent years due to its potential role in various biological processes and its implications in human health. As a protein encoded by a gene located on chromosome 11, research into C11orf49 has revealed its involvement in immune responses and possibly in inflammatory diseases. Studies suggest that C11orf49 may interact with other signaling pathways, highlighting its significance in cellular communication and regulation. Additionally, the protein's structure and functional characteristics remain under investigation, making it a compelling target for recombinant protein production. By generating and studying recombinant C11orf49, researchers aim to elucidate its biological functions, understand its mechanisms of action, and explore its therapeutic potential. This research is particularly relevant in the context of personalized medicine, where understanding the role of C11orf49 could lead to targeted treatments for conditions related to immune system dysregulation. Thus, the exploration of C11orf49 as a recombinant protein is essential for advancing our understanding of its biology and its potential utility in clinical applications.











